{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:13:54Z","timestamp":1786990434110,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100005646","name":"Actelion Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005646","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.ijcard.2015.08.080","type":"journal-article","created":{"date-parts":[[2015,8,9]],"date-time":"2015-08-09T04:30:24Z","timestamp":1439094624000},"page":"52-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["FUTURE-2: Results from an open-label, long-term safety and tolerability extension study using the pediatric FormUlation of bosenTan in pUlmonary arterial hypeRtEnsion"],"prefix":"10.1016","volume":"202","author":[{"given":"Rolf M.F.","family":"Berger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila G.","family":"Haworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Dulac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Fraisse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazzareno","family":"Gali\u00e8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Dunbar","family":"Ivy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Ja\u00efs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Miera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika B.","family":"Rosenzweig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Efficace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andjela","family":"Kusic-Pajic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurice","family":"Beghetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"25 Suppl.","key":"10.1016\/j.ijcard.2015.08.080_bb0005","doi-asserted-by":"crossref","first-page":"D42","DOI":"10.1016\/j.jacc.2013.10.032","article-title":"Definitions and diagnosis of pulmonary hypertension","volume":"62","author":"Hoeper","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2015.08.080_bb0010","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1183\/09031936.00056110","article-title":"Pulmonary arterial hypertension: a comparison between children and adults","volume":"37","author":"Barst","year":"2011","journal-title":"Eur. Respir. J."},{"issue":"1 Suppl","key":"10.1016\/j.ijcard.2015.08.080_bb0015","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/j.jacc.2009.04.011","article-title":"Diagnosis and assessment of pulmonary arterial hypertension","volume":"54","author":"Badesch","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"issue":"25 Suppl","key":"10.1016\/j.ijcard.2015.08.080_bb0020","doi-asserted-by":"crossref","first-page":"D117","DOI":"10.1016\/j.jacc.2013.10.028","article-title":"Pediatric pulmonary hypertension","volume":"62","author":"Ivy","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2015.08.080_bb0025","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0140-6736(11)61621-8","article-title":"Clinical features of paediatric pulmonary hypertension: a registry study","volume":"379","author":"Berger","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2015.08.080_bb0030","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1183\/09059180.00008211","article-title":"REVEAL: a contemporary US pulmonary arterial hypertension registry","volume":"21","author":"McGoon","year":"2012","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.ijcard.2015.08.080_bb0035","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1161\/CIRCULATIONAHA.111.026591","article-title":"Survival in childhood pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management","volume":"125","author":"Barst","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2015.08.080_bb0040","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.jacc.2014.02.575","article-title":"Survival differences in pediatric pulmonary arterial hypertension: clues to a better understanding of outcome and optimal treatment strategies","volume":"63","author":"Zijlstra","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2015.08.080_bb0045","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1161\/CIRCULATIONAHA.110.969584","article-title":"Pediatric pulmonary hypertension in the Netherlands: epidemiology and characterization during the period 1991 to 2005","volume":"124","author":"van Loon","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2015.08.080_bb0050","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1136\/hrt.2008.150086","article-title":"Treatment and survival in children with pulmonary arterial hypertension: the UK Pulmonary Hypertension Service for Children 2001\u20132006","volume":"95","author":"Haworth","year":"2009","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2015.08.080_bb0055","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/eurheartj\/eht072","article-title":"Current era survival of patients with pulmonary arterial hypertension associated with congenital heart disease: a comparison between clinical subgroups","volume":"35","author":"Manes","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2015.08.080_bb0060","doi-asserted-by":"crossref","first-page":"252","DOI":"10.4103\/2045-8932.109931","article-title":"Clinical trials in neonates and children: report of the pulmonary hypertension academic research consortium pediatric advisory committee","volume":"3","author":"Adatia","year":"2013","journal-title":"Pulm. Circ."},{"key":"10.1016\/j.ijcard.2015.08.080_bb0065","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jacc.2005.01.066","article-title":"Effects of long-term bosentan in children with pulmonary arterial hypertension","volume":"46","author":"Rosenzweig","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2015.08.080_bb0070","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1136\/hrt.2005.072314","article-title":"Response to bosentan in children with pulmonary hypertension","volume":"92","author":"Maiya","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2015.08.080_bb0075","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1183\/09031936.00053510","article-title":"Long-term efficacy of bosentan in treatment of pulmonary arterial hypertension in children","volume":"38","author":"Hislop","year":"2011","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ijcard.2015.08.080_bb0080","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.ahj.2007.06.003","article-title":"Long-term effect of bosentan in adults versus children with pulmonary arterial hypertension associated with systemic-to-pulmonary shunt: does the beneficial effect persist?","volume":"154","author":"van Loon","year":"2007","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcard.2015.08.080_bb0085","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0009-9236(03)00005-5","article-title":"Pharmacokinetics, safety, and efficacy of bosentan in pediatric patients with pulmonary arterial hypertension","volume":"73","author":"Barst","year":"2003","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ijcard.2015.08.080_bb0090","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1111\/j.1365-2125.2009.03532.x","article-title":"Pharmacokinetic and clinical profile of a novel formulation of bosentan in children with pulmonary arterial hypertension: the FUTURE-1 study","volume":"68","author":"Beghetti","year":"2009","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ijcard.2015.08.080_bb0095","author":"ICH Harmonised Tripartite Guideline"},{"key":"10.1016\/j.ijcard.2015.08.080_bb0100","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S2213-2600(14)70090-6","article-title":"Pulmonary hypertension: smaller kids, smaller steps","volume":"2","author":"Berger","year":"2014","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.ijcard.2015.08.080_bb0105","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0140-6736(01)06250-X","article-title":"Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study","volume":"358","author":"Channick","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2015.08.080_bb0110","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa012212","article-title":"Bosentan therapy for pulmonary arterial hypertension","volume":"346","author":"Rubin","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2015.08.080_bb0115","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(08)60919-8","article-title":"Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial","volume":"371","author":"Gali\u00e8","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2015.08.080_bb0120","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.amjcard.2010.06.064","article-title":"Long-term outcomes in children with pulmonary arterial hypertension treated with bosentan in real-world clinical settings","volume":"106","author":"Ivy","year":"2010","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2015.08.080_bb0125","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1203\/PDR.0b013e318179954c","article-title":"Safety experience with bosentan in 146 children 2\u201311years old with pulmonary arterial hypertension: results from the European Postmarketing Surveillance program","volume":"64","author":"Beghetti","year":"2008","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ijcard.2015.08.080_bb0130","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.amjcard.2010.02.023","article-title":"Outcome of pediatric patients with pulmonary arterial hypertension in the era of new medical therapies","volume":"106","author":"van Loon","year":"2010","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2015.08.080_bb0135","doi-asserted-by":"crossref","first-page":"343","DOI":"10.7326\/0003-4819-115-5-343","article-title":"Survival in patients with primary pulmonary hypertension. Results from a national prospective registry","volume":"115","author":"D'Alonzo","year":"1991","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijcard.2015.08.080_bb0140","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1161\/01.CIR.99.9.1197","article-title":"Vasodilator therapy for primary pulmonary hypertension in children","volume":"99","author":"Barst","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2015.08.080_bb0145","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/0735-1097(94)00391-3","article-title":"Primary pulmonary hypertension in children: clinical characterization and survival","volume":"25","author":"Sandoval","year":"1995","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2015.08.080_bb0150","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1183\/09059180.00011109","article-title":"Paediatric pulmonary hypertension: monitoring progress and identifying unmet needs","volume":"18","author":"Beghetti","year":"2009","journal-title":"Eur. Respir. Rev."}],"updated-by":[{"DOI":"10.1016\/j.ijcard.2016.08.333","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2016,11,15]],"date-time":"2016-11-15T00:00:00Z","timestamp":1479168000000}}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527315303090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527315303090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T12:49:52Z","timestamp":1737982192000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527315303090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":30,"alternative-id":["S0167527315303090"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2015.08.080","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FUTURE-2: Results from an open-label, long-term safety and tolerability extension study using the pediatric FormUlation of bosenTan in pUlmonary arterial hypeRtEnsion","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2015.08.080","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}